Journal profile · Oncology
Technology in Cancer Research & Treatment
ISSN 1533-0346 · eISSN 1533-0338 · SAGE Publications Inc. · UNITED STATES · Bimonthly · Founded 2002
Technology in Cancer Research & Treatment: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.79; fully open access; APC about USD 2,650; review about 2 months (community reports); community-reported acceptance: about 80%; 163 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Technology in Cancer Research & Treatment is published by SAGE Publications Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Radiation Therapy and Dosimetry and MicroRNA in disease regulation, together about 28.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal HighlightsImpact Factor: 2.8Indexed In: Clarivate Analytics: Social Science Index Expanded (SCIE), PubMed Central (PMC), PubMed: MEDLINE, Scopus, EMBASE, Index Medicus, and the Directory of Open Access Journals (DOAJ)Fast and double-anonymized peer review by dedicated Associate Editors and Editorial Board MembersGlobal visibility due to international audience of multidisciplinary researchersPublication is subject to payment of an article processing charge (APC)Submit hereTechnology in Cancer Research and Treatment (TCRT) is an open access, peer-reviewed journal which focuses on developments in the detection, diagnosis, prognosis and treatment of cancer. Please see the Aims and Scope tab for further information.This journal is a member of the Committee on Publication Ethics (COPE).Submission InformationSubmit your manuscript at https://mc.manuscriptcentral.com/tcrt. Please see the Submission Guidelines tab for more information on how to submit your article to the journal.Open access article processing charge (APC) informationPublication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.The article processing charge (APC) for this journal is currently $3200 (+VAT where applicable); Brief Report APCs are $2560, Commentaries are $2560, Original Article (Technical Edit) and Research Article (Technical Edit) are $4200 and Technical Note APCs are $2560.The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here. In some cases, manuscripts may be eligible for a discount or waiver. Please see further details here.ContactPlease direct any peer review-related queries to tct@sagepub.com. All other queries can be sent to TCRTeditor@sagepub.com.Why Publish Open Access with TCRTVisibility and Impact: Anyone anywhere in the world can read, use and cite your researchRigorous Standards: Double-anonymized peer review policySpeed: Less than 2 months from submission to first decision and 4 weeks from acceptance to online publicationFlexibility: No page limits or page charges, and authors can publish full data sets, figures, tables, etcCopyright: Authors retain copyright under a Creative Commons LicenseUseful LinksSubmission PageSubmission Guidelines (PDF)SAGE Open Access Main PageSAGE Open Access FAQsContact the Editor: Applonia.Rose@sagepub.co.ukOther information This journal changed its publication mode from subscription to open access in 2016.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editorial board by country: 103 in mainland China (about 18%); most named United States 208, Mainland China 103, Italy 46, India 29, Türkiye 26 (574 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy16.6%
- Radiation Therapy and DosimetryMedicine6%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.9%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.7%
- Medical Imaging Techniques and ApplicationsMedicine5.7%
- Radiomics and Machine Learning in Medical ImagingMedicine5.5%
- Lung Cancer Diagnosis and TreatmentMedicine4.9%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.79LetPub ·
- Impact factor (publisher)
- 2.7Publisher website ·
- 5-year impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 5.2LetPub ·
- SJR 2026-06
- 0.67LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 56LetPub ·
- h-index
- 86OpenAlex ·
- i10-index
- 1,636OpenAlex ·
- 2-year mean citedness
- 3.14OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.82%LetPub ·
Volume
- Articles per year
- 144LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 3,183 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 162 | 162 | 61 |
| 2025 | 163 | 163 | 440 |
| 2024 | 216 | 216 | 1,196 |
| 2023 | 239 | 239 | 2,267 |
| 2022 | 239 | 239 | 2,699 |
| 2021 | 303 | 303 | 4,247 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 80%LetPub ·
- Acceptance rate (publisher)
- 19.8%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Acceptance to publication
- 21 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,650 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,650 | — | — | |
| Publisher website | USD 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 300 words
- Reference style
- AMA
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted10, with length limits
- case studyView our topical sections currently accepting submissions View our Special Collections currently accepting submissions View our Author Resource page for guidanc…Length not stated
- commentarychanges or trends related to the field. Commentaries must be less than 2,500 words and have no more than 20 references. Abstract structure: Unmain text ≤ 2,500 words
- editorialesearch and therapy. The word limit for editorial articles is maximum 2,000 words and up to 20 references. In the context of a Special Collecmain text ≤ 2,000 words
- literature reviewView our topical sections currently accepting submissions View our Special Collections currently accepting submissions View our Author Resource page for guidanc…Length not stated
- mini reviewnges and potential future developments. Mini Reviews should be approximately 2000 words. The abstract should not exceed 300 words and should be strmain text ≤ 2,000 words
- original research articleView our topical sections currently accepting submissions View our Special Collections currently accepting submissions View our Author Resource page for guidanc…Length not stated
- original research articlesOriginal Research articlesLength not stated
- perspectivemitted as an original research article. Perspectives Description: Perspectives are opinion pieces and should not exceed 3,000 words and 30 references. Perspecti…main text ≤ 3,000 words
- research articleView our topical sections currently accepting submissions View our Special Collections currently accepting submissions View our Author Resource page for guidanc…Length not stated
- reviewView our topical sections currently accepting submissions View our Special Collections currently accepting submissions View our Author Resource page for guidanc…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Technology in Cancer Research & Treatment is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publish…
Source ↗Publisher website ·- Peer review Peer review policy
The following summary describes the peer review process for this journal: Identity transparency: Double-anonymized Reviewer interacts with: Executive Editor, Deputy Editor, Managing Editors, Associate Editors Review information published: Review reports (author opt in) Review reports (reviewer opt in) Author/editor communication Reviewer identities (reviewer opt in) Editor identities Your manuscri…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2002
- ISSN
- 1533-0346
- Electronic ISSN
- 1533-0338
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Technology in Cancer Research & Treatment
What CAS zone is Technology in Cancer Research & Treatment in?
In the 2025 upgraded edition of the CAS Journal Ranking, Technology in Cancer Research & Treatment is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Technology in Cancer Research & Treatment?
The latest impact factor listed by LetPub is 2.79; CiteScore 5.2, h-index 86.
How long does peer review take at Technology in Cancer Research & Treatment?
Authors report an average review time of about 2 months; the community-reported acceptance is “about 80%”; the journal's website gives an acceptance rate of 19.8%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Technology in Cancer Research & Treatment?
According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: AMA; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Technology in Cancer Research & Treatment based?
Of the 574 board members whose country the journal's board page names, 103 (about 18%) are in mainland China; the countries named most often are United States (208), Mainland China (103) and Italy (46). Counted from the institutions listed on the board page; for reference only.
Which databases index Technology in Cancer Research & Treatment?
According to LetPub and DOAJ records, Technology in Cancer Research & Treatment is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE and PubMed; that list has not been checked against each database.
Is Technology in Cancer Research & Treatment open access, and what is the APC?
Technology in Cancer Research & Treatment is a fully open-access journal. APC about USD 2,650.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .